Vehicle only

BIOLOGICAL2 trials

Sponsors

University of California, San Francisco, AlloCure Inc.

Conditions

Acute Kidney InjuryPersistent Corneal Epithelial Defects

Phase 2

Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

TerminatedNCT01165450

University of California, San FranciscoPersistent Corneal Epithelial Defects

Start: 2011-11-30End: 2014-02-28Updated: 2015-05-07

A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects

TerminatedNCT01602328

AlloCure Inc.Acute Kidney Injury

Start: 2012-06-30End: 2014-08-31Updated: 2014-08-06

Related Papers

Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial

BMJ Open2022-02-018 citations

Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury.

2018-11-2852 citations

Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury.

2018-08-2321 citations

MSCs Do Not Reduce Time to Recovery in Postcardiopulmonary Bypass AKI

MD Conference Express2015-01-01